<?xml version="1.0" encoding="UTF-8"?>
<p id="Par52">Memantine, an antagonist of Î±7-nAChR and NMDA receptors may lessen ACE2 receptors expression and reduce oxidative stress and inflammation [
 <xref ref-type="bibr" rid="CR51">51</xref>]. Early treatment with anti-oxidants such as N-acetyl cysteine during COVID-19 can be a way to control the excessive inflammation and cell damage [
 <xref ref-type="bibr" rid="CR40">40</xref>]. Various randomized controlled trials, pilot studies, case reports and in vitro and in vivo studies confirmed that 
 <italic>Nigella sativa</italic> (black cumin seeds) that showed antiviral, antioxidant, anti-inflammatory, immunomodulatory, bronchodilatory, antihistaminic, antitussive activities, could be considered as an adjuvant therapy along with repurposed conventional drugs for management of COVID-19 patients [
 <xref ref-type="bibr" rid="CR100">100</xref>]. It further renders the importance of homocysteine-dependent trans-sulfuration pathway in COVID-19 infection. Hence, Vitamin B6, folic acid, and Vitamin B12 should also be included in the treatment regimen for SARS CoV-2 infections [
 <xref ref-type="bibr" rid="CR101">101</xref>].
</p>
